Simplex Trading’s NeuroOne Medical Technologies NMTC Stock Holding History

Simplex Trading’s Portfolio NMTC Stock Details NMTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,241	Closed	-$11K	–	9566
2025 Q3	$11K	Buy	+2,241	New	+$11K	﹤0.01%	7824
2024 Q4	–	Sell	-172	Closed	-$858	–	9268
2024 Q3	$1K	Buy	+172	New	+$860	﹤0.01%	8230
2024 Q2	–	Sell	-287	Closed	-$1.8K	–	9475
2024 Q1	$2K	Sell	287 -200	-41%	-$1.51K	﹤0.01%	8426
2023 Q4	$4K	Buy	487 +483	+12,075%	+$3.56K	﹤0.01%	7988
2023 Q3	$0	Sell	4 -1	-20%	-$7	﹤0.01%	9448
2023 Q2	$0	Sell	5 -49	-91%	-$397	﹤0.01%	9602
2023 Q1	$0	Buy	54 +9	+20%	+$83	﹤0.01%	9775
2022 Q4	$0	Buy	+45	New	+$402	﹤0.01%	9992

Other funds holding NMTC

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Simplex Trading's NMTC Position: Q4 2025 in Review

Simplex Trading sold out of NeuroOne Medical Technologies (NMTC) in Q4 2025, closing a stake of 2,241 shares — an estimated $11K sold.

Simplex Trading first reported a position in NMTC in Q4 2022 and held it in 8 quarters. The position peaked at $11K in Q3 2025. 37 funds tracked by Wall St. Rank hold NMTC as of Q4 2025.

Simplex Trading reported no remaining NeuroOne Medical Technologies position as of Q4 2025 after selling out during the quarter.
Simplex Trading sold 2,241 NeuroOne Medical Technologies shares in Q4 2025, an estimated $11K.
Simplex Trading first reported a position in NeuroOne Medical Technologies in Q4 2022 and held it in 8 quarters.
Simplex Trading's NeuroOne Medical Technologies position peaked at $11K in Q3 2025.
37 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.